Faculty of Medical Sciences

Staff Profile

Professor Ann Daly

Professor of Pharmacogenetics and Associate Dean for Internationalisation (Faculty of Medical Sciences)


BA in Biochemistry (1978, University of Dublin)

PhD in Biochemistry (1982, University of Dublin)

FBPhS (2012)

Present appointment

Professor of Pharmacogenetics, Institute of Cellular Medicine, Newcastle University, UK (since August 2004)

Previous appointments

Senior Lecturer, School of Clinical and Laboratory Sciences, Newcastle University (1998-2004).

Lecturer, Department of Pharmacological Sciences, Newcastle University (1992-1998).

Senior Research Associate, Department of Pharmacological Sciences, Newcastle University (1989-1992).

Research Associate, Medical Molecular Biology Group and Department of Dermatology, Newcastle University (1984-1989).

Postdoctoral Research Assistant, Department of Molecular Biology, University of Geneva, Switzerland (1982-1984).

Other current appointments

Chair IUPHAR (The International Union of Basic and Clinical Pharmacology) Drug Metabolism and Drug Transporter section executive board (2014-2018)

President-elect, International Society for the Study of Xenobiotics (2018-2019)

Member, Pharmacovigilance Expert Advisory Group, Commission on Human Medicines, MHRA (2017-2021)

Member IUPHAR Pharmacogenetics subcommittee

Committee member UK Pharmacogenetics and Stratified Medicine Network (since 2014)

Executive Editor, British Journal of Clinical Pharmacology

Editorial Board Member, Clinical Pharmacology & Therapeutics, Pharmacogenetics & Genomics,  Pharmacogenomics, Pharmacogenomics Journal

Google Scholar: Click here.


Google Scholar link


Scopus link


Research Interests

See also http://www.ncl.ac.uk/medicalsciences/research/groups/drugtox/

Pharmacogenetic studies on the discovery of novel human genetic polymorphisms, their functional significance and their relationship to outcome of drug therapy, susceptibility to adverse drug reactions and susceptibility to complex diseases. These studies are central to the area of personalised (stratified) medicine and a key aim is to translate our findings to simple tests that can be used to determine the most appropriate drug treatment on an individual basis.

I coordinate the iDILIC network on genetics of drug-induced liver injury (see https://www.saeconsortium.org/index.php?q=node/16. )

Research Group members

Dr Sally Coulthard (http://www.ncl.ac.uk/icm/people/profile/sally.coulthard)

Dr Olivier Govaere (http://www.ncl.ac.uk/icm/people/profile/olivier.govaere)

Mr Julian Leathart (http://www.ncl.ac.uk/icm/people/profile/julian.leathart)

Dr Yang-Lin Liu

Ms Emma Scott